Gastrointestinal Oncology
Lillebaelt Hospital’s Clinical Trial Unit is involved in studies of colon cancer and metastatic colorectal cancer, with interest in treatment strategies for locally advanced and advanced disease.
- Neoadjuvant treatment for locally advanced colon cancer
- Therapeutic approaches in metastatic colorectal cancer
- Combination regimens with supportive agents
The hospital’s research activity in this area reflects a focus on medical oncology and disease control in colorectal malignancies.
Multiple Myeloma and Haematology
Research activity includes multiple myeloma, with attention to relapsed and refractory disease, infection prevention, and supportive care in patients who are not eligible for transplantation.
- Relapsed and refractory multiple myeloma
- t(11;14)-positive disease
- Infection prophylaxis and immune support
These studies place emphasis on haematological cancer management and complication reduction in vulnerable patient groups.
Interstitial Lung Disease
The sponsor is active in progressive fibrotic interstitial lung disease, with research directed toward lung function decline and treatment options for chronic fibrosing respiratory disorders.
- Progressive fibrotic interstitial lung disease
- Forced vital capacity outcomes
- Local standard of care in fibrotic lung disease
This area highlights interest in respiratory medicine and the management of progressive pulmonary fibrosis.
Chronic Obstructive Pulmonary Disease
Lillebaelt Hospital also supports research in chronic obstructive pulmonary disease, particularly severe breathlessness and symptom relief in advanced respiratory impairment.
- Severe and very severe COPD
- Breathlessness management
- Symptom-focused respiratory care
The clinical focus in this field is centred on improving functional status and patient comfort in advanced obstructive lung disease.
